Nico Vandervelpen
Nico Vandervelpen is a Series A investor at Limburgse Reconversie Maatschappij focused on Health Care and Biotechnology. Nico Vandervelpen is the co-founder of Bioqube Ventures. Nico attended UHasselt.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Nico Vandervelpen invests in
Stages Nico Vandervelpen invests in
Countries Nico Vandervelpen invests in
Investment Focus
Industry
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Pharmaceutical 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
FF Pharma
|
FF Pharma, a biopharmaceutical company, develops anti-CD40 monoclonal antibody therapy for the treatment of chronic inflammatory diseases like primary biliary cirrhosis and Crohn’s disease. The functions of CD40 in immune regulation suggest that the CD40 pathway may play a role in diseases in which anomalous immune responses, e.g. autoantibodyproduction or chronic inflammation, are a feature. | $4.2M / Series A / Jan 23, 2013 |
Co-Investors
PMV Pharmaceuticals
1 deal together
Vesalius Biocapital Partners
1 deal together
About Limburgse Reconversie Maatschappij
LRM is an investment company that develops and stimulates economic growth in Limburg. We provide a solid foundation so that companies and projects that create jobs in Limburg can grow. Our financial resources and expertise, together with the assets of Limburg, provide a unique breeding ground.
Limburgse Reconversie Maatschappij Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Inne Hesemans
Secretary of the Board
|
|||
Koen Nulens
Senior Investment Manager
|
|||
Luc Driesen
Team Member
|
|||
Rik van Hensberg
Property Manager
|
|||
Tom Aerts
Head of Technology & Services
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Nico Vandervelpen invest in?
Nico Vandervelpen invests primarily in Health Care, Biotechnology and Pharmaceutical startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in The Netherlands. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Nico Vandervelpen last invest?
The most recent investment recorded for Nico Vandervelpen closed in Jan 2013. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
